Nu Skin Enterprises, Inc.
General ticker "NUS" information:
- Sector: Consumer Staples
- Industry: Household & Personal Products
- Capitalization: $454.1M (TTM average)
Nu Skin Enterprises, Inc. does not follow the US Stock Market performance with the rate: -22.6%.
Estimated limits based on current volatility of 2.2%: low 5.12$, high 5.35$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-05-29, amount 0.06$ (Y4.58%)
- Total employees count: 3100 as of 2024
- China accounted for 13.6% of revenue in the fiscal year ended 2024-12-31
- US accounted for 30.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Sales channel retention, Market competition, Manufacturing disruptions, Technology failures
- Current price 36.7% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.27$, 14.03$]
- 2026-12-31 to 2027-12-31 estimated range: [8.71$, 14.68$]
Financial Metrics affecting the NUS estimates:
- Positive: with PPE of 7.8 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 16.28 > 12.93
- Positive: -5.34 < Operating profit margin, % of 4.43
- Positive: Industry inventory ratio change (median), % of 0.26 <= 0.28
- Negative: 0.74 < Interest expense per share per price, % of 2.83
- Positive: 42.57 < Shareholder equity ratio, % of 57.30 <= 64.23
- Positive: Return on assets ratio (scaled to [-100,100]) of 10.23 > 6.02
- Positive: Investing cash flow per share per price, % of 34.60 > -0.60
- Positive: 2.87 < Industry operating profit margin (median), % of 4.09
Short-term NUS quotes
Long-term NUS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,969.13MM | $1,732.08MM | $1,485.16MM |
| Operating Expenses | $1,920.86MM | $1,883.67MM | $1,419.40MM |
| Operating Income | $48.27MM | $-151.59MM | $65.76MM |
| Non-Operating Income | $-21.69MM | $-23.47MM | $130.43MM |
| Interest Expense | $25.56MM | $26.41MM | $13.95MM |
| Income(Loss) | $26.58MM | $-175.05MM | $196.20MM |
| Taxes | $17.98MM | $-28.46MM | $35.99MM |
| Net Income(Loss)* | $8.60MM | $-146.59MM | $160.20MM |
| Stockholders Equity | $821.97MM | $651.46MM | $805.24MM |
| Inventory | $279.98MM | $190.24MM | $178.64MM |
| Assets | $1,808.63MM | $1,468.91MM | $1,405.31MM |
| Operating Cash Flow | $118.64MM | $111.74MM | $80.29MM |
| Capital expenditure | $58.49MM | $41.58MM | $34.28MM |
| Investing Cash Flow | $-134.50MM | $-37.96MM | $170.66MM |
| Financing Cash Flow | $10.73MM | $-133.18MM | $-202.40MM |
| Earnings Per Share** | $0.17 | $-2.95 | $3.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.